Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?
Saved in:
| Title: | Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation? |
|---|---|
| Authors: | Uzunoglu FG; Department of General, Visceral and Thoracic Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Peccerella T; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany., Hank T; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany., Loos M; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany., Michalski CW; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany., Hackert T; Department of General, Visceral and Thoracic Surgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Neoptolemos JP; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany. |
| Source: | Hepatobiliary surgery and nutrition [Hepatobiliary Surg Nutr] 2026 Feb 01; Vol. 15 (1), pp. 15. Date of Electronic Publication: 2026 Jan 19. |
| Publication Type: | Editorial; Comment |
| Journal Info: | Publisher: AME Publishing Company Country of Publication: China (Republic : 1949- ) NLM ID: 101600750 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2304-3881 (Print) Linking ISSN: 23043881 NLM ISO Abbreviation: Hepatobiliary Surg Nutr Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
